These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35538603)

  • 1. Identification of a Gut Commensal That Compromises the Blood Pressure-Lowering Effect of Ester Angiotensin-Converting Enzyme Inhibitors.
    Yang T; Mei X; Tackie-Yarboi E; Akere MT; Kyoung J; Mell B; Yeo JY; Cheng X; Zubcevic J; Richards EM; Pepine CJ; Raizada MK; Schiefer IT; Joe B
    Hypertension; 2022 Aug; 79(8):1591-1601. PubMed ID: 35538603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive activity of the angiotensin converting enzyme inhibitor quinapril HCl: (S)-2-[(S)-N-[(S)-1-ethoxycarbonyl-3-phenylpropyl) alanyl]-1,2,3,4- tetrahydro-3-isoquinolinecarboxylic acid monohydrochloride in various hypertensive animal models].
    Yaoka O; Aoki K; Nakajima T; Setoguchi M
    Nihon Yakurigaku Zasshi; 1993 Jul; 102(1):35-45. PubMed ID: 8335286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secretory dysfunction of vascular endothelium limits the effect of angiotensin converting enzyme inhibitor quinapril on aggregation of erythrocytes in experimental hypertension.
    Korbut RA; Madej J; Adamek-Guzik T; Korbut R
    J Physiol Pharmacol; 2003 Sep; 54(3):397-408. PubMed ID: 14566078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of quinapril, a new angiotensin-converting enzyme inhibitor, on vasoconstrictor activity in the isolated, perfused mesenteric vasculature of hypertensive rats.
    Major TC; Overhiser RW; Taylor DG; Panek RL
    J Pharmacol Exp Ther; 1993 Apr; 265(1):187-93. PubMed ID: 8474005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial function in mineralocorticoid-NaCl hypertension: influence of angiotensin-converting enzyme inhibition.
    Mäkynen H; Kähönen M; Wu X; Hutri-Kähönen N; Tolvanen JP; Pörsti I
    Pharmacol Toxicol; 1997 Oct; 81(4):180-9. PubMed ID: 9353849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial function in spontaneously hypertensive rats: influence of quinapril treatment.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pörsti I
    Br J Pharmacol; 1995 Jul; 115(5):859-67. PubMed ID: 8548188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and long-term effects of angiotensin converting enzyme inhibition on larger arteries and cardiac hypertrophy: mechanical and structural parameters.
    Benetos A; Albaladejo P; Levy BI; Safar ME
    J Hypertens Suppl; 1994 Jul; 12(4):S21-9. PubMed ID: 7965270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High calcium diet, different antihypertensive agents, and cytosolic free Ca2+ in spontaneously hypertensive rats.
    Arvola P; Kähönen M; Mäkynen H; Wuorela H; Manninen V; Vapaatalo H; Pörsti I
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):702-5. PubMed ID: 7506321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lowering of blood pressure improves endothelial dysfunction by increase of nitric oxide production in hypertensive rats.
    Hatta T; Nakata T; Harada S; Kiyama M; Moriguchi J; Morimoto S; Itoh H; Sasaki S; Takeda K; Nakagawa M
    Hypertens Res; 2002 May; 25(3):455-60. PubMed ID: 12135326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin-converting enzyme inhibition attenuates arterial constrictor responses in experimental hypertension.
    Kähönen M; Mäkynen H; Wu X; Arvola P; Pekki A; Pörsti I
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1701-9. PubMed ID: 8667241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats.
    Benetos A; Levy BI; Lacolley P; Taillard F; Duriez M; Safar ME
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):3196-201. PubMed ID: 9409311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
    Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
    Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril: overview of preclinical data.
    Kaplan HR; Taylor DG; Olson SC
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII6-12. PubMed ID: 2189623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function during antihypertensive treatment with quinapril, a novel angiotensin converting enzyme inhibitor.
    Gupta RK; Kjeldsen SE; Motley E; Weder AB; Zweifler AJ; Julius S
    J Cardiovasc Pharmacol; 1991 Jan; 17(1):13-9. PubMed ID: 1708046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 upregulation in the kidney of uninephrectomized spontaneously hypertensive rats and its modification by the angiotensin-converting enzyme inhibitor quinapril.
    Largo R; Gómez-Garre D; Liu XH; Alonso J; Blanco J; Plaza JJ; Egido J
    Hypertension; 1997 May; 29(5):1178-85. PubMed ID: 9149684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged inhibition of local angiotensin-converting enzyme after single or repeated treatment with quinapril in spontaneously hypertensive rats.
    Nakajima T; Yamada T; Setoguchi M
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):102-7. PubMed ID: 1375675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardioprotective effects of quinapril after myocardial infarction in hypertensive rats.
    Mori T; Nishimura H; Okabe M; Ueyama M; Kubota J; Kawamura K
    Eur J Pharmacol; 1998 May; 348(2-3):229-34. PubMed ID: 9652338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term organ protection by doxazosin and/or quinapril as antihypertensive therapy.
    Gallego-Delgado J; Lazaro A; Gomez-Garre D; Osende JI; Gonzalez-Rubio ML; Herraiz M; Manzarbeitia F; Fortes J; Fernandez-Cruz A; Egido J
    J Nephrol; 2006; 19(5):588-98. PubMed ID: 17136686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.